secwatch / observer

8-K filed May 27, 2026, 4:25 PM ET ticker SNAL CIK 0001886894

regulatory confidence high sentiment negative materiality 0.70

Snail receives Nasdaq extension to Sept 22, 2026 to regain listing compliance

Snail, Inc.

Nasdaq notified Snail on Mar 26, 2026 of non-compliance with minimum $500K net income requirement and alternative standards.
Compliance plan submitted May 11, 2026; Nasdaq accepted on May 20, 2026 with extension to Sept 22, 2026.
If compliance not evidenced by Sept 30, 2026 quarterly filing, Class A common stock subject to delisting.
Snail may pursue equity financing or debt conversion to regain compliance, but no assurance of success.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-025419
form_type: 8-K
ticker: SNAL
cik: 0001886894
company_name: Snail, Inc.
filed_at: 2026-05-27T20:25:45+00:00
discovered_at: 2026-05-27T20:27:00.282553+00:00
generated_at: 2026-05-27T20:27:09.965325+00:00
sec_items: ["8.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-025419
json_url: https://secwatch.observer/filing/0001493152-26-025419.json
markdown_url: https://secwatch.observer/filing/0001493152-26-025419.md
text_url: https://secwatch.observer/filing/0001493152-26-025419.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1886894/000149315226025419/0001493152-26-025419-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1886894/000149315226025419/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

LESL

Leslie's regains Nasdaq compliance for minimum market value of publicly held shares

Leslie's, Inc. June 1, 2026, 4:28 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

VYGR

FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's

Voyager Therapeutics, Inc. June 1, 2026, 8:00 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

EXFY

Expensify regains Nasdaq minimum bid price compliance

Expensify, Inc. May 29, 2026, 5:15 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

SLXN

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp May 29, 2026, 7:00 AM ET regulatory Items 3.03, 5.03, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

MNKD

FDA releases MannKind from Afrezza malignancy study; sBLA for children PDUFA May 29

MANNKIND CORP May 28, 2026, 8:37 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

JAGX

Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc. May 27, 2026, 9:10 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

FCUV

Focus Universal regains Nasdaq equity compliance after Series B conversion and $4M warrant offering

FOCUS UNIVERSAL INC. May 26, 2026, 3:19 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-26-025419

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.